...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

posted on May 30, 2017 12:31PM

Kelsee....we already have FDA approval to run the renal/dialysis trial in US. So if you were searching for a third country/region for a currently ongoing or soon to be ongoing trial.....Resverlogix already has that. However, I am guessing that you were referring to the FDA/US involvement in BETonMACE. 

Share
New Message
Please login to post a reply